Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

Table 2 multivariable regression analysis

Variable	β	SE	p
	Δ CTx
ATV/r vs. EFV	-0.22	0.06	0.002
Age (for one year older)	0.01	0.01	0.009
Log₁₀ HIV RNA (for 1 log₁₀ higher)	0.07	0.02	0.002
	Δ OPG
eGFR cystatin C (< 90 vs. > 90 L/min)	0.21	0.1	0.045

β partial regression coefficient, SE standard error, EFV efavirenz, ATV/r atazanavir/ritonavir, eGFR estimated glomerular filtration rate, CTx C-terminal cross-laps, OPG osteoprotegerin.

ISSN: 1471-2334